Amarin Corp Plc (AMRN)

[Chromosome]

The ROW decline I believe was explained as an initial channel buy in to support launch in various markets that artificially elevated ROW revenue (11.9). Remember revenue is not end user sales but sales into the channel. This initial spike is normal as you want to make sure there is no stock out. The 3.1 million is likely a closer reflection of the fact that they overshot their initial launch forecast. Hopefully demand will increase from here.